Birchview Capital’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $757K | Sell |
|
|||||
|
2025
Q1 | $773K | Buy |
|
|||||
|
2024
Q4 | $567K | Sell |
|
|||||
|
2024
Q3 | $950K | Buy |
|
|||||
|
2024
Q2 | $542K | Hold |
|
|||||
|
2024
Q1 | $546K | Buy |
|
|||||
|
2023
Q4 | $490K | Hold |
|
|||||
|
2023
Q3 | $385K | Hold |
|
|||||
|
2023
Q2 | $360K | Hold |
|
|||||
|
2023
Q1 | $314K | Hold |
|
|||||
|
2022
Q4 | $270K | Hold |
|
|||||
|
2022
Q3 | $580K | Hold |
|
|||||
|
2022
Q2 | $394K | Hold |
|
|||||
|
2022
Q1 | $590K | Hold |
|
|||||
|
2021
Q4 | $529K | Hold |
|
|||||
|
2021
Q3 | $698K | Hold |
|
|||||
|
2021
Q2 | $958K | Hold |
|
|||||
|
2021
Q1 | $1.03M | Buy |
|
|||||
|
2020
Q4 | $570K | Hold |
|
|||||
|
2020
Q3 | $378K | Hold |
|
|||||
|
2020
Q2 | $363K | Hold |
|
|||||
|
2020
Q1 | $230K | Hold |
|
|||||
|
2019
Q4 | $534K | Hold |
|
|||||
|
2019
Q3 | $348K | Buy |
|